Iridex (IRIX) Current Deferred Revenue (2011 - 2026)

Iridex's Current Deferred Revenue history runs 16 years deep, the most recent figure standing at $2.0 million for Q2 2026.

• On a quarterly basis, Current Deferred Revenue fell 2.39% year-over-year to $2.0 million in Q2 2026; TTM through Apr 2026 was $2.0 million, a 2.39% decrease from a year earlier, with the FY2026 full-year figure at $2.2 million, down 79.48% from the prior year.
• Current Deferred Revenue retreated to $2.0 million in Q2 2026 per IRIX's latest filing, from $2.2 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $14.9 million in Q2 2022 and bottomed at $2.0 million in Q2 2026.
• The 5-year median for Current Deferred Revenue is $2.4 million (2022), against an average of $5.3 million.
• Across the five-year window, Current Deferred Revenue surged 982.72% in 2022 and sank 83.72% in 2023, its largest moves.
• Year by year, Current Deferred Revenue stood at $14.2 million in 2022, then declined by 12.18% to $12.4 million in 2023, then declined by 15.31% to $10.5 million in 2024, then tumbled by 79.02% to $2.2 million in 2025, then declined by 7.61% to $2.0 million in 2026.
• Per Business Quant, the three latest IRIX Current Deferred Revenue figures stand at $2.0 million (Q2 2026), $2.2 million (Q1 2026), and $2.2 million (Q3 2025).